Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

The Pennsylvania Pharmacist Association's Annual Conference Post Show | Part One Mar 09, 2026

Show notes

Welcome to this special three-part press coverage series from the Pharmacy Podcast Network, recorded on location at the Pennsylvania Pharmacists Association Annual Conference, held February 20th through the 22nd at the Hilton Harrisburg.
This series is proudly sponsored by Value Drug Company and the Pennsylvania Pharmacists Care Network — PPCN — as they celebrate their 10th anniversary of advancing pharmacist-led patient care across the Commonwealth. In this episode we hear from:

Margie Lydon - Value Drug Company
Darren Mensch, PharmD, BCPS, BCACP
Hayleigh Monroe - P4 Pharmacy Student
Mayank (Dr. Mak) Amin, PharmD, RPh, MBA
Todd Laser - Value Drug Company
Jonathan Adly - TJM Labs
Jennifer (Pekich) Urso

The Power of Patient 1st Care in Pharmacy and PBM Reform Progress | TWIRx Mar 06, 2026

Show notes

Welcome to another episode of TWIRx – This Week in Pharmacy, where we break down the most important developments impacting the pharmacy profession. This week’s show features leaders from across community pharmacy, health systems, healthcare advocacy, and international patient engagement. From PBM reform to patient-centered care and health system growth in Western Pennsylvania, this episode brings together voices shaping the future of pharmacy.
Sponsored by Sykes & Company, P.A.
Accounting, tax strategy, and advisory services dedicated exclusively to independent pharmacy operators.
Segment 1 Austin Murray Communications and Marketing Director – Sykes & Company, P.A.
We kick off TWIRx with Austin Murray from Sykes & Company, discussing the NCPA Consumer Marketing Campaign designed to educate the public about the value of community pharmacies.
Austin shares insights on: • The importance of telling the community pharmacy story directly to consumers
• Why independent pharmacies remain essential healthcare access points
• The evolving state of independent pharmacy nationwide
• Continued momentum around PBM Reform
• Strategic accounting and tax advantages pharmacy operators should understand in today’s challenging reimbursement environment
Austin also explains how pharmacy-focused accounting firms like Sykes & Company help owners navigate reimbursement pressure, tax planning, and business strategy.
Segment 2 Mark Duman
Pharmacy 50 Award Winner – United Kingdom
International healthcare thought leader Mark Duman joins TWIRx to discuss one of the most important principles in healthcare transformation:
The patient must come first. Mark shares his perspective on:
• Why healthcare systems must remain patient-centered
• How pharmacy can lead the way in improving patient outcomes
• Lessons learned from patient engagement initiatives in the UK healthcare system
• Why meaningful healthcare innovation always begins by focusing on the patient experience
Mark emphasizes that when healthcare professionals keep the patient as the constant focus, better pharmacy care and stronger health systems follow.
Segment 3 Dr. Laura Mark, PharmD Vice President of Pharmacy – Allegheny Health Network
Next, we welcome Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network (AHN), who shares exciting news about new pharmacy operations facilities recently built in Butler County, Pennsylvania.
Todd and Laura also reflect on their shared roots growing up in Butler County, while discussing how AHN is investing in the future of pharmacy.
Topics include:
• The new pharmacy operations infrastructure in Western Pennsylvania
• How AHN is expanding pharmacy services across the Greater Pittsburgh region
• The role of health system pharmacy in improving access to care
• Strategic positioning for future healthcare growth and integration
AHN continues to strengthen its pharmacy operations as a key component of coordinated patient care throughout the region.
Segment 4 Eric Pusey Independent Pharmacy Owner – Pennsylvania
Closing out this week’s episode, pharmacy owner Eric Pusey joins TWIRx to discuss the latest updates on PBM Reform in Pennsylvania.
In 2024, Pennsylvania enacted Act 77, a landmark law aimed at increasing oversight and fairness in pharmacy benefit management.
Eric explains how the law:
• Grants new regulatory authority to the Pennsylvania Insurance Department
• Restricts PBM patient steering to pharmacies owned or affiliated with benefit managers
• Improves transparency requirements for PBM operations
• Establishes payment protections intended to level the playing field for community pharmacies
Patient steering practices have long limited competition and reduced patient choice. Eric shares why these reforms represent an important step toward protecting both patients and independent pharmacy providers across the Commonwealth.
Listen & Subscribe
Stay informed on the business, policy, and innovation shaping the pharmacy profession.
Follow TWIRx – This Week in Pharmacy on the Pharmacy Podcast Network, featuring conversations with the leaders and advocates advancing pharmacy practice.

PBM Reform Update from CPhA | PBM Reform with APCI Mar 05, 2026

Show notes

In this episode, listeners get to know the leadership of the California Pharmacists Association (CPhA), exploring their professional journeys, personal backgrounds, and the experiences that shaped their commitment to advancing the pharmacy profession.

Susan Bonilla, CEO of the California Pharmacists Association, joins Dr. Sean Kim, PharmD, Vice President of Practice & Professional Development at CPhA, to discuss California’s progress in pharmacy benefit manager (PBM) reform. As the largest state in the nation, California continues to play a significant role in shaping policies that strengthen patient access to pharmacy care and improve transparency within the prescription drug supply chain. Bonilla and Kim share insights into the reforms California has achieved, the legislative and regulatory priorities currently underway, and how these efforts may influence PBM reform conversations across the country.

The PBM Reform Podcast is sponsored by the American Pharmacy Cooperative, Inc. (APCI). APCI’s sponsorship supports the production of this program but does not imply affiliation with the individual guests, nor endorsement of the views, opinions, or insights shared by podcast hosts or guests. APCI does not endorse any statements or content discussed on the PBM Reform Podcast or across the Pharmacy Podcast Network. Please reach out to the APCI Communication's team for additional information.

Peddling a Fantasy: How Drugmakers are Misleading State Lawmakers| Essential: Pharmacy Compounding Podcast APC Mar 04, 2026

Show notes

In this edition of Essential, we look at two major issues facing pharmacy compounding. First is a state-by-state effort by pharma companies to pass laws restricting compounding, and second is a cryptic statement from the FDA about possible limitations on compounding with GLP-1 ingredients. They’re both Very Big Deals for pharmacists across the country.
Links
FDA statement on GLP-1 drugs: https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs
… and APC’s response: https://a4pc.org/news/apc-responds-to-fdas-glp-1-statement
Stay up to date on our state Compounding Defense Initiative: compounding.com
Join APC today: https://a4pc.org/membership
Find us on social:
LinkedIn: https://www.linkedin.com/company/a4pcrx/
Facebook: https://www.facebook.com/a4pcrx/
Instagram: https://www.instagram.com/a4pcrx/

LTC Pharmacy at a Crossroads: Maximum Fair Price, the IRA, and What DC Means for 2026 and Beyond Mar 02, 2026

Show notes

In this episode of Framework Focus, Dr. Dae Lee breaks down the regulatory and reimbursement shifts reshaping long-term care (LTC) pharmacy. With the Inflation Reduction Act (IRA) moving from policy theory to operational reality, Medicare’s Maximum Fair Price (MFP) program, Part D redesign, and inflation rebate enforcement are now active forces that LTC operators must navigate.
This conversation moves beyond headlines and into real-world implications: cash flow risk, administrative burden, contracting exposure, and strategic readiness for closed-door and combo LTC pharmacies.
Key Discussion Points

Medicare Drug Price Negotiation Is Now Operational
The IRA authorizes Medicare to negotiate prices for certain high-spend Part D drugs, with the first 10 Maximum Fair Prices (MFPs) effective January 1, 2026. This marks a structural shift in federal drug pricing and directly impacts LTC dispensing economics.
Maximum Fair Price and LTC Reimbursement Compression
MFP caps reimbursement on selected drugs, creating potential margin compression if acquisition costs and payment timing are misaligned. For LTC pharmacies operating on tight spreads and high-volume chronic utilization, even small deltas can materially affect profitability.
Medicare Transaction Facilitator (MTF) and Payment Timing Risk
The MTF system introduces new payment mechanics between manufacturers, plans, and pharmacies. LTC pharmacies must understand how effectuation and reconciliation work, particularly if payment timing differs from traditional Part D adjudication flows. Cash flow modeling becomes essential.
Administrative Complexity and Claims Reconciliation
Identifying which NDCs are subject to MFP, managing claim reversals, handling price disputes, and monitoring plan-level compliance will increase administrative workload. LTC pharmacies will need structured internal workflows to prevent reimbursement leakage.
Dispensing Fees and the LTC Service Intensity Problem
Unlike retail, LTC pharmacy includes compliance packaging, emergency kits, cycle fills, consultant pharmacist oversight, and regulatory documentation. Current IRA implementation does not automatically adjust dispensing or supply fees to reflect this complexity, raising sustainability concerns.
Congressional Efforts to Stabilize LTC Pharmacy
Legislative proposals such as the Preserving Patient Access to LTC Pharmacies Act aim to create supply fee protections tied to MFP drugs. The episode explores whether policy corrections are likely — and how quickly DC can realistically respond.
Expansion of Negotiated Drug Lists
The initial 10 negotiated drugs are only the beginning. Additional rounds of negotiation are underway, expanding exposure across more therapeutic classes. LTC pharmacies must treat MFP as a growing structural feature — not a limited pilot.
Part D Redesign and the $2,100 Out-of-Pocket Cap
Beginning in 2026, the redesigned Part D benefit changes liability distribution among plans, manufacturers, and CMS. The new out-of-pocket cap alters plan incentives and may lead to tighter utilization management, formulary shifts, and network recalibration — all of which LTC pharmacies must monitor closely.
Inflation Rebates and Market Distortion
The IRA’s inflation rebate provisions penalize manufacturers for price increases above inflation benchmarks. While not directly adjudicated at the pharmacy counter, these provisions influence manufacturer pricing strategy, launch pricing behavior, and downstream PBM negotiations — indirectly affecting LTC acquisition costs.
Strategic Readiness as a Competitive Advantage
The episode concludes with practical recommendations:
• Conduct an MFP exposure audit across top-dispensed NDCs
• Reassess PBM contracts and network participation clauses
• Model cash flow under delayed reimbursement scenarios
• Educate facility partners on regulatory changes
• Build internal compliance tracking specific to negotiated drugs

Why This Matters Now
For LTC pharmacies, this is not simply a policy conversation — it is a structural shift in reimbursement architecture. As federal oversight expands and pricing authority evolves, operational precision and legal literacy will define which organizations adapt successfully.
About our guest: Dr. Dae Lee, Pharm.D, Esq., CPBS Shareholder - Buchanan Ingersoll & Rooney PC Email: dae.lee@bipc.com
Dae Y. Lee is a pharmacist-attorney and Certified Pharmacy Benefits Specialist™ (CPBS™) who represents pharmacies, healthcare stakeholders, and plan sponsors in high-stakes disputes and regulatory matters involving Pharmacy Benefit Managers (PBMs) and government payors. Drawing on his dual training as a pharmacist and attorney, Dae focuses his practice on defending clients in audits, investigations, enforcement actions and complex reimbursement and compliance matters.
Dae routinely represents pharmacies nationwide in PBM and payor audits, including Fraud, Waste and Abuse (FWA) investigations, extrapolation disputes, overpayment recoupments, credentialing denials, network suspensions and terminations. He advises pharmacies on compliance with applicable state pharmacy fair audit laws, PBM provider manuals, and reimbursement standards, with the goal of minimizing financial exposure while preserving network participation and business continuity.

Pharmacy Profit Summit 2026 + Rare Disease Day 2026 | TWIRx Feb 27, 2026

Show notes

On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026.
First, we welcome Dr. Lisa Faast, PharmD, founder of DiversifyRx, to discuss the Pharmacy Profit Summit 2026 and how independent pharmacies can strengthen margins, diversify revenue streams, and build sustainable growth models in today’s reimbursement environment.
Then, we turn to Rare Disease Day 2026 with Richard Faris, PharmD, Chief Commercial & Clinical Officer at PANTHERx Rare, to discuss specialty pharmacy leadership, pharmacist impact, and new patient feedback data revealing communication gaps in rare disease care.
Segment 1: Pharmacy Profit Summit 2026
Guest: Dr. Lisa Faast, PharmD | Founder, DiversifyRx
Dr. Faast joins us to break down the vision behind Pharmacy Profit Summit 2026 — an event designed to equip pharmacy owners with practical strategies to increase profitability while maintaining clinical excellence.
Key Topics Covered: • Why independent pharmacies must move beyond traditional dispensing revenue
• Diversification strategies including niche services and high-value offerings
• Real-world financial benchmarks pharmacy owners should track
• How mindset, leadership, and data discipline drive sustainable profitability
• The importance of collaboration and shared intelligence among pharmacy entrepreneurs
The Pharmacy Profit Summit is not just about revenue — it’s about equipping pharmacy owners to compete intelligently in a rapidly consolidating healthcare market.
Segment 2: Rare Disease Day 2026
Guest: Richard Faris, PharmD | PANTHERx Rare Pharmacy
In recognition of Rare Disease Day 2026, we are honored to welcome Richard Ferris, PharmD, to discuss the critical role pharmacists play in specialty pharmacy and rare disease care.
PANTHERx Rare recently released survey findings examining patient and caregiver experiences within rare disease treatment journeys.
Key Study Highlights: • 90% of patients and caregivers report delays due to communication gaps
• 68% report waiting for updates from providers, pharmacies, or insurers
• 90% say they manage the care process themselves
• 72% desire a dedicated care coordinator
• 73% agree it is unclear who is responsible for coordinating rare disease care
Despite advances in specialty therapeutics, patients are still asking for the fundamentals: clear communication, coordinated care, and personalized support.
Richard discusses: • The growing importance of specialty pharmacists as care coordinators
• Why rare disease patients often feel burdened by system fragmentation
• How specialty pharmacy can close communication gaps
• The need for pharmacist-led continuity in complex therapy management
Rare Disease Day reminds us that specialty pharmacy is not only about high-cost medications — it is about human connection, long-term coordination, and advocacy for patients navigating some of the most complex clinical journeys in healthcare. From business sustainability to patient-centered specialty care, this episode reinforces two realities:
Pharmacy must remain financially strong to survive.
Pharmacists must remain clinically present to lead.
As the profession evolves, profitability and patient advocacy are not opposing forces — they are interdependent pillars of pharmacy’s future.
Listen now and join the conversation shaping Pharmacy in 2026.

Why Taking Fuller Advantage of Technology You Already Own Could Be Your Most Profitable Strategy | Pharmacy Crossroads Feb 26, 2026

Show notes

Many pharmacy owners invest in expensive technology but fail to fully utilize the system’s secondary and valuable features. This is a costly mistake! It leaves significant operational efficiencies and profit opportunities unrealized.
This program also invites managers to carefully review their tech vendor invoices to ensure new charges have not been added or that fees have not been quietly increased for features in their software agreements.
Kevin Minassian, President of DataScan, notes his company provides a wide range of profit-enhancing services at no additional cost while competitors often add additional fees. Visit www.datascanpharmacy.com for more information.

Thug Drugs: Policy | Pain Pod Feb 25, 2026

Show notes

“Thug Drugs: Policy”
THUG DRUGS! With a name like that, it has to be good! Even better than Smuckers (Age old ad slogan for jelly/jam)!
In this episode of the Pain Pod, we’re going to dive into Thug Drug Policies, here in our country, and beyond.
Come one, come all, to the Pain Pod!!!
www.painguy.us

Pediatric Pharmacist Review: The Pharmacist Families Didn’t Know They Needed...Until Now | Pediatric Pharmacist Review Feb 24, 2026

Show notes

Welcome back to the Pediatric Pharmacist Review Podcast.
Today’s Pharmacist Spotlight features Brian Seyboth, a pediatric hematology/oncology pharmacist and the first full-time pharmacist at Perfecting Peds.
In this episode, Brian shares a powerful patient care win that shaped his career and highlights why pediatric oncology pharmacy is both highly technical and deeply personal. We discuss how pharmacists optimize complex medication regimens, support families during difficult diagnoses, and improve outcomes through collaborative decision-making.
Brian also reflects on mentoring residents, expanding pharmacist integration into pediatric care teams, and adapting clinical pharmacy services into a virtual environment.
Whether you're a student, resident, or practicing clinician, this conversation shows how pharmacists can transform pediatric care through expertise and compassion.
Let’s get started.

Bagging Better Benefits: The Grocery PBM Disruptor | PBM Reform Feb 23, 2026

Show notes

How Kroger does PBM and the future of community pharmacy is clinical encounters.

Related Podcasts